BULLISHWHALES
BullishWhales · Analysts · Analyst Profile
BW Score Rank#313 of 347

Edward Woo

Ascendiant Capital · Equity Research Analyst
EstablishedRating since 2021No new ratings since Jun 2025

Analyst rating accuracy & track record

Edward Woo is an equity research analyst at Ascendiant Capital. Bullish Whales has scored 89 of their stock calls across 28 companies. Their picks beat their sector 26% of the time over the next 12 months, and their price targets were reached 22% of the time within a year.

Win % vs sector
26%
PT Hit % (12mo)
22%
Avg sector-excess
−25.6%
Scored calls
89
Tickers
28
Tier
Established

Track record

Bullish Whales has scored 89 of Edward Woo's stock calls across 28 companies, dating back to 2021. Their rated stocks beat their own sector 26% of the time over the next 12 months. On a typical call, a Woo pick returned −25.6% more than its sector over the following year.

Of the scored calls, 89 were bullish (Buy). Most of their coverage sits in Technology. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
LUCDLucid Diagnostics Inc
Buy$7.75Jun 2025−42.1%Miss
GNSSGenasys Inc
Buy$5.50Jun 2025−45.6%Miss
KSCPKnightscope Inc
Buy$26.00Jun 2025−85.9%Miss
QUBTQuantum Computing Inc
Buy$22.00Jun 2025−81.8%Hit
PHUNPhunware Inc
Buy$12.50Jun 2025−94.7%Miss
PAVMPAVmed Inc
Buy$19.00Jun 2025−88.9%Miss
OTLKOUTLOOK THERAPEUTICS INC
Buy$21.00Jun 2025−77.8%Miss
AMTXAemetis Inc
Buy$20.00Jun 2025−3.7%Miss
ATOSAtossa Genetics Inc
Buy$7.50Jun 2025−82.6%Miss
PSTVPlus Therapeutics Inc
Buy$20.50Jun 2025−50.3%Miss
TZOOTravelzoo
Buy$25.00May 2025−31.6%Miss
NDRAENDRA Life Sciences Inc
Buy$46.00May 2025+43.0%Miss
INTZIntrusion Inc
Buy$11.00May 2025−122.9%Miss
SINTSINTX Technologies Inc
Buy$28.00May 2025−35.8%Miss
PDEXPro-Dex Inc
Buy$56.00May 2025+41.2%Hit
COCHEnvoy Medical Inc.
Buy$9.50May 2025−71.5%Miss
CINGCingulate Inc
Buy$61.00May 2025−16.2%Miss
GRIGRI Bio Inc.
Buy$34.00May 2025−109.6%Miss
SOPASociety Pass Inc
Buy$15.00May 2025−112.6%Miss
DUOTDuos Technologies Group Inc
Buy$9.00Apr 2025−41.9%Hit
KSCPKnightscope Inc
Buy$30.00Apr 2025−67.8%Miss
QUBTQuantum Computing Inc
Buy$14.00Apr 2025−27.8%Hit
SURGSurgepays Inc
Buy$8.75Apr 2025−103.5%Miss
PSTVPlus Therapeutics Inc
Buy$20.00Apr 2025−73.8%Miss
LUCDLucid Diagnostics Inc
Buy$7.50Apr 2025−10.0%Miss
NDRAENDRA Life Sciences Inc
Buy$50.00Apr 2025+57.6%Miss
COCHEnvoy Medical Inc.
Buy$9.25Apr 2025−58.9%Miss
CINGCingulate Inc
Buy$60.00Apr 2025+30.9%Miss
SINTSINTX Technologies Inc
Buy$30.00Apr 2025+39.2%Miss
PHUNPhunware Inc
Buy$12.00Apr 2025−83.3%Miss
PAVMPAVmed Inc
Buy$19.50Apr 2025−66.4%Miss
SOPASociety Pass Inc
Buy$14.00Apr 2025−65.5%Miss
ATOSAtossa Genetics Inc
Buy$7.25Apr 2025−52.0%Miss
DXRDaxor Corporation
Buy$25.00Mar 2025+37.8%Miss
ALZNAlzamend Neuro Inc
Buy$20.00Mar 2025−81.7%Miss
GRPNGroupon Inc
Buy$19.00Mar 2025−54.0%Hit
AMTXAemetis Inc
Buy$19.00Mar 2025+22.4%Miss
OTLKOUTLOOK THERAPEUTICS INC
Buy$24.00Feb 2025−80.1%Miss
DUOTDuos Technologies Group Inc
Buy$7.50Dec 2024+81.0%Hit
ALZNAlzamend Neuro Inc
Buy$32.00Dec 2024−94.0%Miss
GNSSGenasys Inc
Buy$5.50Dec 2024−35.1%Miss
SURGSurgepays Inc
Buy$8.50Dec 2024−21.2%Miss
PSTVPlus Therapeutics Inc
Buy$19.00Dec 2024−54.8%Miss
LUCDLucid Diagnostics Inc
Buy$7.00Dec 2024+33.5%Miss
PAVMPAVmed Inc
Buy$19.00Dec 2024−62.6%Miss
ATOSAtossa Genetics Inc
Buy$7.00Dec 2024−41.7%Miss
COCHEnvoy Medical Inc.
Buy$9.00Dec 2024−67.9%Miss
GRIGRI Bio Inc.
Buy$13.00Dec 2024−92.8%Miss
SOPASociety Pass Inc
Buy$16.00Dec 2024+59.1%Miss
INTZIntrusion Inc
Buy$11.00Dec 2024+134.6%Miss
Go to

Edward Woo: analyst track record FAQ

Is Edward Woo a good stock analyst?

Yes, by track record. Edward Woo ranks number 313 of 347 of the analysts Bullish Whales scores, with a BW Score of 0 out of 100. Past results do not guarantee future ones.

What is Edward Woo's win rate?

Edward Woo's win rate is 26%. Across 89 scored calls, their rated stocks beat their sector 26% of the time over the next 12 months. On a typical call they returned −25.6% more than the sector.

What stocks and sectors does Edward Woo cover?

Edward Woo covers 28 companies, with the most coverage in Technology. See the ratings table above for every scored call and its outcome.

Are Edward Woo's price targets accurate?

Edward Woo's price targets are reached within 12 months 22% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Edward Woo's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Bullish Whales score analyst accuracy?

Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Edward Woo rank among Wall Street analysts?

Edward Woo ranks number 313 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30